HAART and its effects on the heartIssue Date: January 2010 Vol. 5 No. 1
Sarah Delgado, ANCP-BC and Kathryn Dort, FNP-BC
Many patients with HIV/AIDS are doing well on highly active antiretroviral therapy (HAART). Yet HAART can increase cardiovascular risks by reducing high-density lipoprotein levels, raising triglyceride levels, and causing insulin resistance.
You must be logged in as a subscriber to view this article.